Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/13199
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Phillips, P A | - |
dc.contributor.author | Hutchins, A M | - |
dc.contributor.author | Burrell, Louise M | - |
dc.contributor.author | Risvanis, John | - |
dc.contributor.author | Johnston, Colin I | - |
dc.date.accessioned | 2015-05-16T02:59:37Z | |
dc.date.available | 2015-05-16T02:59:37Z | |
dc.date.issued | 1994-07-11 | - |
dc.identifier.citation | European Journal of Pharmacology; 259(3): 325-9 | en_US |
dc.identifier.other | PUBMED | en |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/13199 | en |
dc.description.abstract | Arginine vasopressin binding site characterisation was performed on purified nuclei and plasma membranes from livers of Sprague-Dawley rats. [125I][d(CH2)5,Sarc7,Arg8]vasopressin, a selective V1 vasopressin receptor antagonist radioligand, bound to the nuclei in a protein concentration and time dependent manner. Scatchard analysis of nuclear binding sites revealed a single binding site with maximal binding site density (Bmax) of 115 +/- 13 fmol/mg protein and affinity (KD) of 5.2 +/- 0.7 nM. Plasma membrane binding demonstrated a Bmax of 529 +/- 25 fmol/mg protein and KD of 1.9 +/- 0.1 nM. The displacement profile for nuclear binding sites using vasopressin analogues was similar to that for plasma membrane binding sites and was typical of a V1 vasopressin receptor type. There was no evidence of V2-like vasopressin receptor binding using [3H]des-Gly-NH9(2)[d(CH2)5,D-Ile2,Ile4,Arg8]vasopressi n, a selective V2 vasopressin receptor radioligand, in the nuclear or membrane fractions. These results suggest the existence of nuclear V1-like vasopressin binding sites. | en_US |
dc.language.iso | en | en |
dc.subject.other | Animals | en |
dc.subject.other | Arginine Vasopressin.analogs & derivatives.pharmacokinetics | en |
dc.subject.other | Cell Membrane.drug effects.metabolism | en |
dc.subject.other | Cell Nucleus.drug effects.metabolism | en |
dc.subject.other | DNA.biosynthesis | en |
dc.subject.other | Female | en |
dc.subject.other | In Vitro Techniques | en |
dc.subject.other | Ligands | en |
dc.subject.other | Liver.drug effects.metabolism | en |
dc.subject.other | Protein Biosynthesis | en |
dc.subject.other | Rats | en |
dc.subject.other | Rats, Sprague-Dawley | en |
dc.subject.other | Receptors, Vasopressin.drug effects.metabolism | en |
dc.subject.other | Vasopressins.pharmacokinetics | en |
dc.title | V1-like [Arg8]vasopressin binding sites occur in rat hepatocyte nuclei. | en_US |
dc.type | Journal Article | en_US |
dc.identifier.journaltitle | European Journal of Pharmacology | en_US |
dc.identifier.affiliation | Medicine (University of Melbourne) | en_US |
dc.description.pages | 325-9 | en |
dc.relation.url | https://pubmed.ncbi.nlm.nih.gov/7982462 | en |
dc.type.content | Text | en_US |
dc.type.austin | Journal Article | en |
local.name.researcher | Burrell, Louise M | |
item.grantfulltext | none | - |
item.openairetype | Journal Article | - |
item.languageiso639-1 | en | - |
item.fulltext | No Fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.cerifentitytype | Publications | - |
crisitem.author.dept | Cardiology | - |
crisitem.author.dept | General Medicine | - |
crisitem.author.dept | Medicine (University of Melbourne) | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.